Marco Perez

Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

COVID-19 Resources » Vaccine Update » Visitor Policy »

5.0/5

1 Patient Ratings »

35 Patient Reviews »

Biography

Dr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and is co-PI in the Apple Heart Study, a clinical trial using the Apple Watch to screen for atrial fibrillation. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He is particularly interested in studying the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram to identify patients at risk for atrial fibrillation and athletes at risk for life-threatening arrhythmias due to conditions such as hypertrophic cardiomyopathy. His genetic studies have led to the discovery of promising novel therapeutic targets that his group is now studying at a functional level. Dr. Perez receives funding from NIH/NHLBI (R01), Apple Inc., the Weston Havens Foundation, The Stanford Cardiovascular Division and the Stanford SPARK program.

View Full Biography »

Professional Summary

Professional Education

Board Certification: American Board of Internal Medicine, Clinical Cardiac Electrophysiology (2011)
Fellowship: Stanford University Medical Center (2010) CA
Fellowship: Stanford University School of Medicine (2007) CA

Residency: Massachusetts General Hospital (2004) MA

Internship: Massachusetts General Hospital (2002) MA

Medical Education: Harvard University Health Services (2001) MA

Fellowship, Stanford, Electrophysiology (2010)

Fellowship, Stanford, Cardiology (2007)

Residency, Maassachusetts General Hospital, Internal Medicine (2004)

Honors & Awards

Dean's Fellow Research Award, Stanford University (2006-2008)
Department of Medicine Teaching Award, Stanford University (2014)
Fellow to Faculty Award, American Heart Association (2011-2016)

Finalist, FGTB Young Investigator Award, American Heart Association (2013)

Harold Amos Faculty Development Award, Robert Wood Johnson Foundation (2012-2016)

Loan Repayment Program Award, NIH (20010-2014)

National Research Service Award, NIH (2006-2008)

R01 Research Project Grant (1R01HL136390-01 ), NIH/NHLBI (2017-2022)

SPARK Award, Stanford University (2014-2015)

Administrative Appointments

Director, Stanford Inherited Cardiac Arrhythmia Clinic (2013 - Present)
Director, Stanford Cardiac Electrocardiography Laboratory (2017 - Present)

Publications

Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy
Haddad, F., Perez, M., Fleischmann, D., Valantine, H., & Hunt, S. A. (2006). Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(11), 1367–70.
Prognostic value of the computerized ECG in Hispanics
Perez, M. V., Yaw, T. S., Myers, J., & Froelicher, V. F. (2007). Prognostic value of the computerized ECG in Hispanics. CLINICAL CARDIOLOGY, 30(4), 189–94.
Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery
Bravata, D. M., Gienger, A. L., McDonald, K. M., Sundaram, V., Perez, M. V., Varghese, R., … Hlatky, M. A. (2007). Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. ANNALS OF INTERNAL MEDICINE, 147(10), 703–U139.

Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing
Dewey, F. E., Perez, M., Hadley, D., Freeman, J. V., Wang, P., Ashley, E. A., … Froelicher, V. F. (2009). Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 20(2), 193–99.

Added Value of a Resting ECG Neural Network That Predicts Cardiovascular Mortality
Perez, M. V., Dewey, F. E., Tan, S. Y., Myers, J., & Froelicher, V. F. (2009). Added Value of a Resting ECG Neural Network That Predicts Cardiovascular Mortality. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 14(1), 26–34.

Isolated Disease of the Proximal Left Anterior Descending Artery Comparing the Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery
Kapoor, J. R., Gienger, A. L., Ardehali, R., Varghese, R., Perez, M. V., Sundaram, V., … Bravata, D. M. (2008). Isolated Disease of the Proximal Left Anterior Descending Artery Comparing the Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery. JACC-CARDIOVASCULAR INTERVENTIONS, 1(5), 483–91.

Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy
Le, V.-V., Perez, M. V., Wheeler, M. T., Myers, J., Schnittger, I., & Ashley, E. A. (2009). Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy. AMERICAN HEART JOURNAL, 158(3), E27–E34.

Electrocardiographic predictors of atrial fibrillation
Perez, M. V., Dewey, F. E., Marcus, R., Ashley, E. A., Al-Ahmad, A. A., Wang, P. J., & Froelicher, V. F. (2009). Electrocardiographic predictors of atrial fibrillation. AMERICAN HEART JOURNAL, 158(4), 622–28.

Adding an Electrocardiogram to the Pre-participation Examination in Competitive Athletes: A Systematic Review
Perez, M., Fonda, H., Le, V.-V., Mitiku, T., Ray, J., Freeman, J. V., … Froelicher, V. F. (2009). Adding an Electrocardiogram to the Pre-participation Examination in Competitive Athletes: A Systematic Review. CURRENT PROBLEMS IN CARDIOLOGY, 34(12), 586–662.

Addition of the Electrocardiogram to the Preparticipation Examination of College Athletes
Le, V.-V., Wheeler, M. T., Mandic, S., Dewey, F., Fonda, H., Perez, M., … Froelicher, V. (2010). Addition of the Electrocardiogram to the Preparticipation Examination of College Athletes. CLINICAL JOURNAL OF SPORT MEDICINE, 20(2), 98–105.

Inappropriate pacing in a patient with managed ventricular pacing: What is the cause?
Perez, M. V., Al-Ahmad, A. A., Wang, P. J., & Turakhia, M. P. (2010). Inappropriate pacing in a patient with managed ventricular pacing: What is the cause? HEART RHYTHM, 7(9), 1336–37.

Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels
Perez, M. V., Wheeler, M., Ho, M., Pavlovic, A., Wang, P., & Ashley, E. A. (2008). Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 1(2), 155–65.

Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure
Dewey, F. E., Perez, M. V., Wheeler, M. T., Watt, C., Spin, J., Langfelder, P., … Ashley, E. A. (2011). Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure. CIRCULATION-CARDIOVASCULAR GENETICS, 4(1), 26–U129.

Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome
Perez, M. V., Kumarasamy, N. A., Owens, D. K., Wang, P. J., & Hlatky, M. A. (2011). Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 4(1), 76–84.

Interpretation of the Electrocardiogram of Young Athletes
Uberoi, A., Stein, R., Perez, M. V., Freeman, J., Wheeler, M., Dewey, F., … Froelicher, V. (2011). Interpretation of the Electrocardiogram of Young Athletes. CIRCULATION, 124(6), 746–57.

The Impact of ST Elevation on Athletic Screening
Leo, T., Uberoi, A., Jain, N. A., Garza, D., Chowdhury, S., Freeman, J. V., … Froelicher, V. (2011). The Impact of ST Elevation on Athletic Screening. CLINICAL JOURNAL OF SPORT MEDICINE, 21(5), 433–40.

Early Repolarization in an Ambulatory Clinical Population
Uberoi, A., Jain, N. A., Perez, M., Weinkopff, A., Ashley, E., Hadley, D., … Froelicher, V. (2011). Early Repolarization in an Ambulatory Clinical Population. CIRCULATION, 124(20), 2208–14.

The prognostic value of early repolarization with ST-segment elevation in African Americans
Perez, M. V., Uberoi, A., Jain, N. A., Ashley, E., Turakhia, M. P., & Froelicher, V. (2012). The prognostic value of early repolarization with ST-segment elevation in African Americans. HEART RHYTHM, 9(4), 558–65.

Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives
Santangeli, P., Di Biase, L., Burkhardt, D. J., Horton, R., Sanchez, J., Bai, R., … Al-Ahmad, A. (2012). Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives. JOURNAL OF CARDIOVASCULAR MEDICINE, 13(2), 108–124.

Semantic Confusion: The Case of Early Repolarization and the J Point
Perez, M. V., Friday, K., & Froelicher, V. (2012). Semantic Confusion: The Case of Early Repolarization and the J Point. AMERICAN JOURNAL OF MEDICINE, 125(9), 843–44.

Use and overuse of left ventriculography
Witteles, R. M., Knowles, J. W., Perez, M., Morris, W. M., Spettell, C. M., Brennan, T. A., & Heidenreich, P. A. (2012). Use and overuse of left ventriculography. AMERICAN HEART JOURNAL, 163(4), 617-?

Prognostic Implications of Q Waves and T-Wave Inversion Associated With Early Repolarization
Uberoi, A., Sallam, K., Perez, M., Jain, N. A., Ashley, E., & Froelicher, V. (2012). Prognostic Implications of Q Waves and T-Wave Inversion Associated With Early Repolarization. MAYO CLINIC PROCEEDINGS, 87(7), 614–19.

Effects of Postmenopausal Hormone Therapy on Incident Atrial Fibrillation The Women's Health Initiative Randomized Controlled Trials
Perez, M. V., Wang, P. J., Larson, J. C., Virnig, B. A., Cochrane, B., Curb, J. D., … Stefanick, M. L. (2012). Effects of Postmenopausal Hormone Therapy on Incident Atrial Fibrillation The Women's Health Initiative Randomized Controlled Trials. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 5(6), 1108–16.

From bedside to bench
Perez, M., & Froelicher, V. (2013). From bedside to bench. JOURNAL OF ELECTROCARDIOLOGY, 46(2), 114–15.

Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study.
Perez, M. V., Wang, P. J., Larson, J. C., Soliman, E. Z., Limacher, M., Rodriguez, B., … Stefanick, M. L. (2013). Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study. Heart , 99(16), 1173–78.

p300/MDM2 complexes participate in MDM2-mediated p53 degradation
Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z. X., … Livingston, D. M. (1998). p300/MDM2 complexes participate in MDM2-mediated p53 degradation. MOLECULAR CELL, 2(4), 405–415.

Personalized Medicine and Cardiovascular Disease: From Genome to Bedside
Personalized Medicine and Cardiovascular Disease: From Genome to Bedside. (2011). Current Cardiovascular Risk Reports, 5.

Taming Rare Variation With Known Biology in Long QT Syndrome.
Perez, M. V., & Ashley, E. A. (2013). Taming Rare Variation With Known Biology in Long QT Syndrome. Circulation. Cardiovascular Genetics, 6(3), 227–229.

Prognostic implications of the J wave ECG patterns.
Yong, C. M., Perez, M., & Froelicher, V. (2013). Prognostic implications of the J wave ECG patterns. Journal of Electrocardiology, 46(5), 408–10.

J wave patterns and their prognostic value in African Americans.
Perez, M. V., & Froelicher, V. (2013). J wave patterns and their prognostic value in African Americans. Journal of Electrocardiology, 46(5), 442–45.

African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative.
Perez, M. V., Hoffmann, T. J., Tang, H., Thornton, T., Stefanick, M. L., Larson, J. C., … Risch, N. (2013). African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative. American Heart Journal, 166(3), 566–72.

Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?
Abraham, J. E. M., Larson, J., Chung, M. K., Curtis, A. B., Lakshminarayan, K., Newman, J. D., … Wassertheil-Smoller, S. (2013). Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation? American Journal of Medicine, 126(12), 1143 e1–8.

Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.
Hlatky, M. A., Ray, R. M., Burwen, D. R., Margolis, K. L., Johnson, K. C., Kucharska-Newton, A., … Stefanick, M. L. (2014). Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circulation. Cardiovascular Quality and Outcomes, 7(1), 157–62.

Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy.
Finocchiaro, G., Knowles, J. W., Pavlovic, A., Perez, M., Magavern, E., Sinagra, G., … Ashley, E. A. (2014). Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy. American Journal of Cardiology, 113(2), 361–67.

Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
Azarbal, F., Singh, M., Finocchiaro, G., Le, V.-V., Schnittger, I., Wang, P., … Perez, M. (2014). Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. Heart , 100(8), 624–30.

Patterns and prognosis of all components of the J-wave pattern in multiethnic athletes and ambulatory patients.
Muramoto, D., Yong, C. M., Singh, N., Aggarwal, S., Perez, M., Ashley, E., … Froelicher, V. (2014). Patterns and prognosis of all components of the J-wave pattern in multiethnic athletes and ambulatory patients. American Heart Journal, 167(2), 259–66.

Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) study.
Zhang, Z.-M., Rautaharju, P. M., Soliman, E. Z., Manson, J. A. E., Martin, L. W., Perez, M., … Prineas, R. J. (2013). Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) study. Circulation. Heart Failure, 6(4), 655–661.

Variation in Use of Left Ventriculography in the Veterans Affairs Health Care System
Heidenreich, P. A., Lin, S., Knowles, J. W., Perez, M., Maddox, T. M., Ho, M. P., … Witteles, R. M. (2013). Variation in Use of Left Ventriculography in the Veterans Affairs Health Care System. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 6(6), 687–93.

Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy.
Finocchiaro, G., Haddad, F., Pavlovic, A., Sinagra, G., Schnittger, I., Knowles, J. W., … Ashley, E. (2014). Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy. Journal of Cardiac Failure, 20(4), 236–43.

Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing.
Priest, J. R., Ceresnak, S. R., Dewey, F. E., Malloy-Walton, L. E., Dunn, K., Grove, M. E., … Ashley, E. A. (2014). Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing. Heart Rhythm , 11(10), 1707–13.

Electrocardiographic Repolarization-Related Variables as Predictors of Coronary Heart Disease Death in the Women's Health Initiative Study.
Rautaharju, P. M., Zhang, Z.-M., Vitolins, M., Perez, M., Allison, M. A., Greenland, P., & Soliman, E. Z. (2014). Electrocardiographic Repolarization-Related Variables as Predictors of Coronary Heart Disease Death in the Women's Health Initiative Study. Journal of the American Heart Association, 3(4).

Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women.
Azarbal, F., Stefanick, M. L., Salmoirago-Blotcher, E., Manson, J. A. E., Albert, C. M., LaMonte, M. J., … Perez, M. V. (2014). Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. Journal of the American Heart Association, 3(4).

Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval.
Seyerle, A. A., Young, A. M., Jeff, J. M., Melton, P. E., Jorgensen, N. W., Lin, Y., … Avery, C. L. (2014). Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval. Epidemiology (Cambridge, Mass.), 25(6), 790–8.

P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery
Wong, J. K., Lobato, R. L., Pinesett, A., Maxwell, B. G., Mora-Mangano, C. T., & Perez, M. V. (2014). P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 28(6), 1497–1504.

Association Between Success Rate and Citation Count of Studies of Radiofrequency Catheter Ablation for Atrial Fibrillation Possible Evidence of Citation Bias
Perino, A. C., Hoang, D. D., Holmes, T. H., Santangeli, P., Heidenreich, P. A., Perez, M. V., … Turakhia, M. P. (2014). Association Between Success Rate and Citation Count of Studies of Radiofrequency Catheter Ablation for Atrial Fibrillation Possible Evidence of Citation Bias. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 7(5), 687–92.

Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval
Seyerle, A. A., Young, A. M., Jeff, J. M., Melton, P. E., Jorgensen, N. W., Lin, Y., … Avery, C. L. (2014). Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval. EPIDEMIOLOGY, 25(6), 790–98.

Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment.
Finocchiaro, G., Haddad, F., Knowles, J. W., Caleshu, C., Pavlovic, A., Homburger, J., … Ashley, E. A. (2015). Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. JACC. Heart Failure, 3(5), 408–18.

Limitations of Current AHA Guidelines and Proposal of New Guidelines for the Preparticipation Examination of Athletes
Dunn, T. P., Pickham, D., Aggarwal, S., Saini, D., Kumar, N., Wheeler, M. T., … Froelicher, V. F. (2015). Limitations of Current AHA Guidelines and Proposal of New Guidelines for the Preparticipation Examination of Athletes. CLINICAL JOURNAL OF SPORT MEDICINE, 25(6), 472–77.

Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High-risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF)
Turakhia, M. P., Ullal, A. J., Hoang, D. D., Than, C. T., Miller, J. D., Friday, K. J., … Heidenreich, P. A. (2015). Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High-risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). CLINICAL CARDIOLOGY, 38(5), 285–92.

Pacemaker Therapy in Atrial Fibrillation
Park, S., Wang, P. J., Zei, P. C., Hsia, H. H., Turakhi, M., Perez, M. V., & Al-Ahmad, A. A. (2013). Pacemaker Therapy in Atrial Fibrillation. Journal of Cardiology and Vascular Medicine, 1.

Systematic Comparison of Digital Electrocardiograms From Healthy Athletes and Patients With Hypertrophic Cardiomyopathy.
Bent, R. E., Wheeler, M. T., Hadley, D., Knowles, J. W., Pavlovic, A., Finocchiaro, G., … Perez, M. V. (2015). Systematic Comparison of Digital Electrocardiograms From Healthy Athletes and Patients With Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 65(22), 2462–63.

Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women.
Schmiegelow, M. D., Hedlin, H., Mackey, R. H., Martin, L. W., Vitolins, M. Z., Stefanick, M. L., … Hlatky, M. A. (2015). Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women. Journal of the American Heart Association, 4(5).

Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients
Bent, R. E., Wheeler, M. T., Hadley, D., Froelicher, V., Ashley, E., & Perez, M. V. (2015). Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients. JOURNAL OF ELECTROCARDIOLOGY, 48(3), 362–67.

Lean body mass and risk of incident atrial fibrillation in post-menopausal women
Azarbal, F., Stefanick, M. L., Assimes, T. L., Manson, J. A. E., Bea, J. W., Li, W., … Perez, M. V. (2016). Lean body mass and risk of incident atrial fibrillation in post-menopausal women. EUROPEAN HEART JOURNAL, 37(20), 1606–13.

Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.
Shiffman, D., Perez, M. V., Bare, L. A., Louie, J. Z., Arellano, A. R., & Devlin, J. J. (2015). Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis. BMC Cardiovascular Disorders, 15, 104-?

Reply to van Oosten et al: "P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery".
Wong, J. K., Maxwell, B. G., & Perez, M. V. (2015). Reply to van Oosten et al: "P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery". Journal of Cardiothoracic and Vascular Anesthesia, 29(5), e63–4.

Gender Differences in Ventricular Remodeling and Function in College Athletes, Insights from Lean Body Mass Scaling and Deformation Imaging
Giraldeau, G., Kobayashi, Y., Finocchiaro, G., Wheeler, M., Perez, M., Kuznetsova, T., … Haddad, F. (2015). Gender Differences in Ventricular Remodeling and Function in College Athletes, Insights from Lean Body Mass Scaling and Deformation Imaging. AMERICAN JOURNAL OF CARDIOLOGY, 116(10), 1610–16.

Long-Term Prognosis of Early Repolarization With J-Wave and QRS Slur Patterns on the Resting Electrocardiogram: A Cohort Study.
Pargaonkar, V. S., Perez, M. V., Jindal, A., Mathur, M. B., Myers, J., & Froelicher, V. F. (2015). Long-Term Prognosis of Early Repolarization With J-Wave and QRS Slur Patterns on the Resting Electrocardiogram: A Cohort Study. Annals of Internal Medicine, 163(10), 747–755.

Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure
Perez, M. V., Pavlovic, A., Shang, C., Wheeler, M. T., Miller, C. L., Liu, J., … Ashley, E. A. (2015). Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(22), 2522–33.

The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
Ermakov, S., Azarbal, F., Stefanick, M. L., LaMonte, M. J., Li, W., Tharp, K. M., … Perez, M. V. (2016). The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women. Heart , 102(17), 1354–62.

Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative
Rodriguez, F., Stefanick, M. L., Greenland, P., Soliman, E. Z., Manson, J. A. E., Parikh, N., … Perez, M. V. (2016). Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative. AMERICAN HEART JOURNAL, 176, 70–77.

Optimizing QT Interval Measurement for the Preparticipation Screening of Young Athletes.
Pickham, D., Hsu, D., Soofi, M., Goldberg, J. M., Saini, D., Hadley, D., … Froelicher, V. F. (2016). Optimizing QT Interval Measurement for the Preparticipation Screening of Young Athletes. Medicine and Science in Sports and Exercise, 48(9), 1745–50.

Early somatic mosaicism is a rare cause of long-QT syndrome
Priest, J. R., Gawad, C., Kahlig, K. M., Yu, J. K., O'Hara, T., Boyle, P. M., … Ashley, E. A. (2016). Early somatic mosaicism is a rare cause of long-QT syndrome. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(41), 11555–60.

Left atrial function and phenotypes in asymmetric hypertrophic cardiomyopathy.
Kobayashi, Y., Wheeler, M., Finocchiaro, G., Ariyama, M., Kobayashi, Y., Perez, M. V., … Haddad, F. (2017). Left atrial function and phenotypes in asymmetric hypertrophic cardiomyopathy. Echocardiography (Mount Kisco, N.Y.).

International criteria for electrocardiographic interpretation in athletes.
Drezner, J. A., Sharma, S., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., … Corrado, D. (2017). International criteria for electrocardiographic interpretation in athletes. British Journal of Sports Medicine.

Orexin: a Missing Link Between Sleep Disorders and Heart Failure?
Pan, S., Cabral, C. S., Ashley, E. A., & Perez, M. V. (2017). Orexin: a Missing Link Between Sleep Disorders and Heart Failure? Current Heart Failure Reports.

Whole Exome Sequencing in Atrial Fibrillation
Lubitz, S. A., Brody, J. A., Bihlmeyer, N. A., Roselli, C., Weng, L.-C., Christophersen, I. E., … Lin, H. (2016). Whole Exome Sequencing in Atrial Fibrillation. PLOS GENETICS, 12(9).

International Recommendations for Electrocardiographic Interpretation in Athletes.
Sharma, S., Drezner, J. A., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., … Corrado, D. (2017). International Recommendations for Electrocardiographic Interpretation in Athletes. Journal of the American College of Cardiology, 69(8), 1057–75.

Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease
Ullal, A. J., Kaiser, D. W., Fan, J., Schmitt, S. K., Than, C. T., Winkelmayer, W. C., … Turakhia, M. P. (2017). Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 28(1), 39–48.

The Associations of Atrial Fibrillation With the Risks of Incident Invasive Breast and Colorectal Cancers
Wassertheil-Smoller, S., McGinn, A. P., Martin, L., Rodriguez, B. L., Stefanick, M. L., & Perez, M. (2017). The Associations of Atrial Fibrillation With the Risks of Incident Invasive Breast and Colorectal Cancers. AMERICAN JOURNAL OF EPIDEMIOLOGY, 185(5), 372–84.

International Recommendations for Electrocardiographic Interpretation in Athletes
Sharma, S., Drezner, J. A., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., … Corrado, D. (2017). International Recommendations for Electrocardiographic Interpretation in Athletes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(8), 1057–75.

Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.
Christophersen, I. E., Rienstra, M., Roselli, C., Yin, X., Geelhoed, B., Barnard, J., … Ellinor, P. T. (2017). Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nature Genetics, 49(6), 946–52.

Athletic Remodeling in Female College Athletes, the "Morganroth Hypothesis" Revisited.
Kooreman, Z., Giraldeau, G., Finocchiaro, G., Kobayashi, Y., Wheeler, M., Perez, M., … Haddad, F. (2018). Athletic Remodeling in Female College Athletes, the "Morganroth Hypothesis" Revisited. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine.

Large Q and S waves in lead III on the electrocardiogram distinguish patients with hypertrophic cardiomyopathy from athletes.
Chen, A. S., Bent, R. E., Wheeler, M., Knowles, J. W., Haddad, F., Froelicher, V., … Perez, M. V. (2018). Large Q and S waves in lead III on the electrocardiogram distinguish patients with hypertrophic cardiomyopathy from athletes. Heart (British Cardiac Society).

Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval.
Lin, H., van Setten, J., Smith, A. V., Bihlmeyer, N. A., Warren, H. R., Brody, J. A., … Isaacs, A. (2018). Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval. Circulation. Genomic and Precision Medicine, 11(5), e002037.

ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals
Bihlmeyer, N. A., Brody, J. A., Smith, A. V., Warren, H. R., Lin, H., Isaacs, A., … Sotoodehnia, N. (2018). ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals. CIRCULATION-CARDIOVASCULAR GENETICS, 11(1).

Genome Editing of Induced PluripotentStem Cells to Decipher CardiacChannelopathy Variant.
Garg, P., Oikonomopoulos, A., Chen, H., Li, Y., Lam, C. K., Sallam, K., … Wu, J. C. (2018). Genome Editing of Induced PluripotentStem Cells to Decipher CardiacChannelopathy Variant. Journal of the American College of Cardiology, 72(1), 62–75.

Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease
Pallisgaard, J. L., Brooks, M. M., Chaitman, B. R., Boothroyd, D. B., Pere, M., & Hlatk, M. A. (2018). Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease. AMERICAN JOURNAL OF MEDICINE, 131(7), 805–12.

Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6
Prins, B. P., Mead, T. J., Brody, J. A., Sveinbjornsson, G., Ntalla, I., Bihlmeyer, N. A., … Jamshidi, Y. (2018). Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6. GENOME BIOLOGY, 19, 87.

Effects of reproductive period duration and number of pregnancies on midlife ECG indices: a secondary analysis from the Women's Health Initiative Clinical Trial
Parikh, N. I., Kapphahn, K., Hedlin, H., Olgin, J. E., Allison, M. A., Magnani, J. W., … Howard, B. V. (2018). Effects of reproductive period duration and number of pregnancies on midlife ECG indices: a secondary analysis from the Women's Health Initiative Clinical Trial. BMJ OPEN, 8(8), e019129.

Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
Lee, S.-P., Ashley, E. A., Homburger, J., Caleshu, C., Green, E. M., Jacoby, D., … Perez, M. V. (2018). Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy. Circulation. Heart Failure, 11(9), e005191.

Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts
Kerr, K. F., Avery, C. L., Lin, H. J., Raffield, L. M., Zhang, Q. S., Browning, B. L., … Whitsel, E. A. (2017). Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts. HEART RHYTHM, 14(11), 1675–84.

Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
Chen, L. Y., Chung, M. K., Allen, L. A., Ezekowitz, M., Furie, K. L., McCabe, P., … Turakhia, M. P. (2018). Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association. Circulation, 137(20), e623–e644.

Video-assisted thoracoscopic surgery to displace the phrenic nerve during endocardial ablation of right atrial tachycardia.
Mesquita, J., Bisla, J., Lee, A., & Perez, M. (2018). Video-assisted thoracoscopic surgery to displace the phrenic nerve during endocardial ablation of right atrial tachycardia. HeartRhythm Case Reports, 4(7), 304–6.

The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association.
Musunuru, K., Ingelsson, E., Fornage, M., Liu, P., Murphy, A. M., Newby, L. K., … Woo, D. (2017). The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association. Circulation. Cardiovascular Genetics, 10(4).

Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study.
Turakhia, M. P., Desai, M., Hedlin, H., Rajmane, A., Talati, N., Ferris, T., … Perez, M. V. (2018). Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. American Heart Journal.

Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women.
Boursiquot, B. C., Larson, J. C., Shalash, O. A., Vitolins, M. Z., Soliman, E. Z., & Perez, M. V. (2018). Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women. American Heart Journal, 209, 68–78.

No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation.
Harati, H., Zanetti, D., Rao, A., Gustafsson, S., Perez, M., Ingelsson, E., & Knowles, J. W. (2019). No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation. Diabetologia.

Comparison of QT Interval Measurement Methods and Correction Formulas in Atrial Fibrillation.
Tooley, J., Ouyang, D., Hadley, D., Turakhia, M., Wang, P., Ashley, E., … Perez, M. (2019). Comparison of QT Interval Measurement Methods and Correction Formulas in Atrial Fibrillation. The American Journal of Cardiology.

Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals.
Roberts, J. D., Hu, D., Heckbert, S. R., Alonso, A., Dewland, T. A., Vittinghoff, E., … Marcus, G. M. (2016). Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals. JAMA Cardiology, 1(4), 442–50.

Athletic Remodeling in Female College Athletes: The "Morganroth Hypothesis" Revisited.
Kooreman, Z., Giraldeau, G., Finocchiaro, G., Kobayashi, Y., Wheeler, M., Perez, M., … Haddad, F. (2019). Athletic Remodeling in Female College Athletes: The "Morganroth Hypothesis" Revisited. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine, 29(3), 224–31.

No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation
Harati, H., Zanetti, D., Rao, A., Gustafsson, S., Perez, M., Ingelsson, E., & Knowles, J. W. (2019). No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation. DIABETOLOGIA, 62(5), 800–804.

Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early-Onset Atrial Fibrillation.
Goodyer, W. R., Dunn, K., Caleshu, C., Jackson, M., Wylie, J., Moscarello, T., … Perez, M. (2019). Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early-Onset Atrial Fibrillation. Circulation. Genomic and Precision Medicine.

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.
Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., … Turakhia, M. P. (2019). Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. The New England Journal of Medicine, 381(20), 1909–17.

Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.
Larsson, S. C., Bäck, M., Rees, J. M., Mason, A. M., & Burgess, S. (2019). Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. European Heart Journal.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Attain Performa(TM) Quadripolar Lead Study »

Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias »

Practice Locations

Cardiac Arrhythmia Service at Palo Alto Stanford, CA

Stanford, CA

Cardiac Arrhythmia Service at Palo Alto

300 Pasteur Drive, 2nd Floor

Stanford , CA 94305

(650) 723-7111

More Clinic Information »

Hypertrophic Cardiomyopathy Center Stanford, CA

Stanford, CA

Hypertrophic Cardiomyopathy Center

300 Pasteur Drive , 2nd Floor, Room A260

Stanford , CA 94305

(650) 736-7878

More Clinic Information »

Stanford Sports Cardiology Stanford, CA

Stanford, CA

Stanford Sports Cardiology

300 Pasteur Drive , 2nd Floor, Room A260

Stanford , CA 94305

(650) 736-7878

More Clinic Information »

Center for Inherited Cardiovascular Disease Stanford, CA

Stanford, CA

Center for Inherited Cardiovascular Disease

300 Pasteur Drive, Heart Clinic 1, Clinic A21

Stanford , CA 94305

(650) 736-7878

More Clinic Information »

Patient Ratings

(1 Ratings)

Overall Rating

5.0/5

View Ratings by Category

5.0/5

Friendliness

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

5.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(35 reviews)

Everybody did a great job, but especially I would like to mention his Colleen Caleshu and her team.

Jun 2019

•

Verified SHC Patient

Dr. Marco Perez is one of the best physicians I've experienced.

Apr 2018

•

Verified SHC Patient

Healthcare all around the world was charged drastically over the last 20 years. People became care providers because they had a passion to help others. As a society we do not take good care of ourselves. The need for good, compassionate healthcare providers is at an all time high but there are to many people pursuing healthcare for a career and not because they have a calling. I live in a small town just under 100,000 people and most of the physicians in Chico, CA treat you like cattle than a person. It's because of these experiences many people, like me, do not seek out answers/care to they're HC problems. I've only had 3 appt. @ Stanford and each time I am there I am treated with dignity and respect. To value me, like this, allows me to relax and trust the system Stanford has in place. Keep it up!

Jan 2018

•

Verified SHC Patient

Amazing!!! Hard to describe the level of intelligence, kindness and relatability.

Jan 2018

•

Verified SHC Patient

Dr. Perez is an excellent physician. I trust him with my care.

Nov 2017

•

Verified SHC Patient

Doctor was excellent and spent plenty of time describing my options for future care.

Oct 2017

•

Verified SHC Patient

Dr. Perez is outstanding!

Sep 2017

•

Verified SHC Patient

Dr. Perez listened to my unusual side effects to medication/Toprol XL. He was considerate and obliging to my request to try to get off med & try a heart monitor (Zio monitor).

Sep 2017

•

Verified SHC Patient

Dr. Perez always spends plenty of time with us. Never hurries us.

Aug 2017

•

Verified SHC Patient

Dr. Perez is a "10"!

Jun 2017

•

Verified SHC Patient

Loved Dr. Perez and his team - I felt very comfortable, and like they truly cared.

May 2017

•

Verified SHC Patient

Dr. Perez was the very best.

Apr 2017

•

Verified SHC Patient

I've the highest respect for the care I've been given by Dr. Marco Perez & his NP Allysone Smith. They are both highly skilled, very friendly & caring, and I can't say enough good about them.

Jan 2017

•

Verified SHC Patient

Excellent beyond expectation.

Dec 2016

•

Verified SHC Patient

Good.

Dec 2016

•

Verified SHC Patient

Everything was great but I was told I would get a call to go over lab results and I'm still waiting I send an e-mail and have not heard back. I have the results on "my health" but I don't know or understand what it all means.

Oct 2016

•

Verified SHC Patient

Dr. Perez is one of the best, most competent, knowledgeable doctors I have ever visited. He has given me excellent care these last close to 2 yrs. I will miss him!

Aug 2016

•

Verified SHC Patient

Good experience - doctor was great! Just took too long to get to him as a new pt.

Aug 2016

•

Verified SHC Patient

always very helpful

Jul 2016

•

Verified SHC Patient

Kate was wonderful again. She carefully explained my condition to me, my progression and further treatment and visits in the future. She really took the time to address my concerns.

Jul 2016

•

Verified SHC Patient

I get the best care from Dr. Perez - I call him my miracle worker. He & his staff cured my arrythmia. My heart now beats at regularly.

Jul 2016

•

Verified SHC Patient

Dr. Perez has helped me through my ICD process and getting used to it. And answers my questions regarding it.

May 2016

•

Verified SHC Patient

Love Dr. Perez & his team. Alyson is great.

Mar 2016

•

Verified SHC Patient

Dr Perez came to see me and talk to me a number of times when I was in the hospital for a week in July. he is a very compassionate person.

Nov 2015

•

Verified SHC Patient

Great professional. Considerate and listens

Oct 2015

•

Verified SHC Patient

spent an hour with my husband and I answering questionsvery compassionate

Aug 2015

•

Verified SHC Patient

Very impressed with Dr. Perez - - he knew my health history - - it was a 1st of documents to review.

Jun 2015

•

Verified SHC Patient

Dr. was very kind and understanding.

Jun 2015

•

Verified SHC Patient

Every person I know that wonders how I am I tell Stanford Hosp. is the very best hosp. I have ever been too.

Apr 2015

•

Verified SHC Patient

Dr. Perez is also very professional & courteous.

Mar 2015

•

Verified SHC Patient

Excellent professional, friendly, knowledgeable, care provider.

Feb 2015

•

Verified SHC Patient

Dr. Marco & nurse Alison are very caring and compassionate. Alison is amazing in her quick response times.

Jul 2014

•

Verified SHC Patient

Never write on comments BUT Doc Perez and his staff is worth it!

Jul 2014

•

Verified SHC Patient

Dr. Perez was excellent in categories.

Apr 2014

•

Verified SHC Patient

Good experience overall.

Feb 2014

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or e-mail the Referral Center at ReferralCenter@stanfordhealthcare.org

Send referrals online
View referral status
Access medical records

Learn More About PRISM » LOG INTO PRISM

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Marco Perez

Cardiac electrophysiologist

Get In Touch

Biography

Professional Summary

Professional Education

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Cardiac Arrhythmia Service at Palo Alto Stanford, CA

Cardiac Arrhythmia Service at Palo Alto

Hypertrophic Cardiomyopathy Center Stanford, CA

Hypertrophic Cardiomyopathy Center

Stanford Sports Cardiology Stanford, CA

Stanford Sports Cardiology

Center for Inherited Cardiovascular Disease Stanford, CA

Center for Inherited Cardiovascular Disease

Patient Ratings

How Our Ratings Work

Patient Reviews

(35 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Marco Perez

Cardiac electrophysiologist

Get In Touch

Biography

Professional Summary

Professional Education

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Cardiac Arrhythmia Service at Palo Alto Stanford, CA

Cardiac Arrhythmia Service at Palo Alto

Hypertrophic Cardiomyopathy Center Stanford, CA

Hypertrophic Cardiomyopathy Center

Stanford Sports Cardiology Stanford, CA

Stanford Sports Cardiology

Center for Inherited Cardiovascular Disease Stanford, CA

Center for Inherited Cardiovascular Disease

Patient Ratings

How Our Ratings Work

Patient Reviews

(35 reviews)

Referring Physicians

PHYSICIAN HELPLINE